Study demonstrates new noninvasive gene expression profile test predicts melanoma risk more accurately than AJCC online predictor tool

Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment, has announced study results demonstrating that its DecisionDx-Melanoma™ gene expression profile...